LENZ Therapeutics, Inc. maintains a speculative but strong buy for small positions, citing favorable risk/reward. Learn more ...

Ordinary income and capital gains are taxed differently, which can influence investment and withdrawal decisions. Read more ...

Explore the CGDG ETF: global, high-quality dividend growers with defensive tilt, active multi-manager strategy, 2% yield & ...

First Solar has fallen enough to again be considered ultra-cheap for investors. Click here to read an analysis of FSLR stock ...

Adeia has been signing multi-year IP licensing deals with Tier-1 technology companies. Click here to read why ADEA stock is a ...

Dana Incorporated is rated a Buy due to margin expansion, balance sheet repair, and diversified growth drivers. Learn more ...

The UAE is preparing to help the U.S. and allies open the Strait of Hormuz by force and is lobbying for a United Nations ...

Management said it is not providing near-term sales targets: "As YARTEMLEA is in the early stages of launch, we are not providing revenue guidance at this time." (Chief Accounting Officer Borges) Near ...

On India, Egan described CoSara as having “a nationwide commercial presence,” “hundreds of laboratory customers,” and “15 PCR tests cleared through India's regulatory pathway,” and said “CoSara has ...

Strategic vehicle selection, like the use of separately managed accounts, and optimizing asset allocations are two ways to ...

Amphenol stands out for its durable competitive advantages, decentralized model, and disciplined acquisition strategy. See ...

South Korean exports surged in March thanks to favourable price effects and strong global chip demand. Read more here.